COVID-19 pandemisinin kardiyovasküler sistem üzerine etkileri

A new virus, which started in Wuhan in December 2019 and spread all over the world in a short time, causing the pandemic was detected. The factor that left all humanity desperate was defined as Serious Acute Respiratory Syndrome-Coronavirus-2 by the World Health Organization (WHO) on February 11, 2020, and the disease that emerged in the clinic was added to the medical literature as COVID-19 (Corona Virus Disease 2019) (1). Although the virus causes pneumonia especially due to lung involvement, as our knowledge about the disease increased, it was observed that it caused cardiovascular events such as stroke, acute coronary syndromes, and embolic events. In clinical studies conducted with the onset of the pandemic, it has been shown that hypersensitivity due to COVID-19 infection is also associated with cardiovascular system (CVS) diseases due to the disease. It has been shown that COVID-19 infection is more severe in patients with CVS and has a negative effect on mortality. In this article, the CVS effects of COVID-19 infection and its effect on individuals with cardiovascular disease were evaluated in the light of the current literature.